Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02637427 · ClinicalTrials.gov registry record · Phase 3
Does Plasma Reduce Bleeding in Patients Undergoing Invasive Procedures
A Phase 3 study, sponsored by Rutgers, The State University of New Jersey.
- Completed
- Registry status
- Phase 3
- Development phase
- 57
- Enrollment target
NCT02637427: Completed Phase 3 study, sponsored by Rutgers, The State University of New Jersey.
NCT02637427 is a Phase 3 study that has completed, run by Rutgers, The State University of New Jersey. The registered enrollment target is 57 participants, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (93% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02637427, a Phase 3 study, has completed, sponsored by Rutgers, The State University of New Jersey.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 57 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate prophylactic fresh frozen plasma transfusion in patients with moderately elevated international normalized ratios (INR) prior to undergoing an invasive procedure.
Primary Outcome
Change from pre-procedure hemoglobin to lowest within 2 days after procedure
Interventions
- BIOLOGICAL Fresh frozen plasma transfusion
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 57 participants |
| Start Date | 2016-02-26 |
| Est. Completion | 2020-11 |
| Phase | Phase 3 |
What the finished NCT02637427 record still lists
NCT02637427 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 57 participants, a relatively small participant target, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (93% lower).
The record links to 0 conditions, and to 1 intervention - of which Fresh frozen plasma transfusion is the first listed.
NCT02637427 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02637427 about?
NCT02637427 is a clinical study titled "Does Plasma Reduce Bleeding in Patients Undergoing Invasive Procedures". The purpose of this study is to evaluate prophylactic fresh frozen plasma transfusion in patients with moderately elevated international normalized ratios (INR) prior to undergoing an invasive procedure.
What is the current status of trial NCT02637427?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 57 participants. The study started on 2016-02-26. Estimated completion is 2020-11.
What interventions are being tested in trial NCT02637427?
The interventions under investigation include: Fresh frozen plasma transfusion (BIOLOGICAL).
Who is sponsoring clinical trial NCT02637427?
This trial is sponsored by Rutgers, The State University of New Jersey, which has 413 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02637427's enrollment target sits among peer trials
57 1827th of 2000 higher than 174 of 2,000 other Phase 3 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03521830 · 57 participants · Phase 2
Nivolumab Alone or Plus Relatlimab or Ipilimumab for Patients With Locally-Advanced Unresectable or Metastatic Basal Cell Carcinoma
- NCT03587701 · 57 participants · Phase 2
Effects of Anakinra in Subjects With Corticosteroid-resistant/Intolerant Meniere's Disease and Autoimmune Inner Ear Disease
- NCT04104126 · 57 participants · NA
Blood Flow Restriction Therapy in Achilles Injury
- NCT04703842 · 57 participants · Phase 1
Modulation of SERCA2a of Intra-myocytic Calcium Trafficking in Heart Failure With Reduced Ejection Fraction
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI